BIOGEN DRN financial statements, including revenue, expenses, profit, and loss

The total revenue of BIIB34 for the last quarter is 10.89 B BRL, and it's 4.40% lower compared to the previous quarter. The net income of Q1 24 is 1.95 B BRL.